PABPC2, standing for Poly(A) Binding Protein Cytoplasmic 2, belongs to the family of poly(A) binding proteins that are renowned for their pivotal roles in the polyadenylation and subsequent translation of eukaryotic mRNAs. These proteins, inclusive of PABPC2, exhibit a strong affinity to the poly(A) tail found on mRNA molecules, a feature that is instrumental in conferring stability to the mRNA, thereby preventing its premature degradation. Furthermore, the binding of PABPC2 and its counterparts to the poly(A) tail is instrumental in ensuring that the mRNA is efficiently exported from the nucleus and aptly positioned on the ribosome for translation. Given the centrality of mRNA in cellular protein synthesis processes, PABPC2's role in safeguarding mRNA stability and facilitating its translation is of paramount importance for the seamless operation of cellular machinery.
PABPC2 Activators are molecules engineered to enhance or potentiate the activity of PABPC2. By amplifying the functionality of PABPC2, such activators could bolster the stabilization of mRNAs and, in turn, fine-tune the subsequent translation processes. This would mean that, in the presence of these activators, there might be a marked increase in protein synthesis rates, given the enhanced stability and readiness of mRNAs for translation. When contemplating the design or discovery of PABPC2 activators, a deep understanding of the protein's molecular architecture, its interaction dynamics with mRNAs, and its collaborative role in the translation initiation complex would be indispensable. The intriguing prospect here lies in the ability of such activators to increase protein synthesis rates, opening avenues for insights into cellular dynamics and offering a microscopic lens to view and influence the molecular ballet within cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA synthesis, potentially affecting the transcription and stability of various mRNAs, including PABPC2. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to DNA and inhibiting transcription, it can alter the expression of several genes, possibly impacting PABPC2. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Known to inhibit nuclear export, which might influence the cytoplasmic levels of nuclear proteins and mRNAs, including PABPC2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can influence gene expression patterns, possibly affecting PABPC2 expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II, potentially affecting transcription of genes, including PABPC2. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
A potent inhibitor of RNA polymerase II, potentially reducing the transcription of various genes, including PABPC2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can influence gene expression by modifying chromatin structure, potentially affecting PABPC2 levels. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
By inhibiting glycolysis, it can impact various cellular processes, potentially influencing PABPC2 expression. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
A chemotherapy drug that causes DNA damage, potentially influencing the transcription and stability of several mRNAs, including PABPC2. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I, which can impact transcription and replication, potentially affecting PABPC2 expression. | ||||||